Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease

NCT01696474 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT01696474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01696474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2012
Completion date
March 27, 2017
Enrollment
21 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

refractory cold agglutinin disease